COLLECTIONS
WORKFLOWS
Recent Finacing
Recent Raise
Axial develops gut-targeted small molecules and live biotherapeutics that modulate the gut–brain axis to treat autism and Parkinson’s disease, supported by a microbiome discovery platform.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
